Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 2.9 Announcement - Transaction in own shares

24 Nov 2022 07:00

RNS Number : 4115H
Allied Minds PLC
24 November 2022
 

24 November 2022

Allied Minds Plc

("the "Company")

 

Rule 2.9 Announcement - Transaction in own shares

 

Allied Minds plc (AIM: ALM, 'Allied Minds' or 'the Company') announces that, in accordance with the terms of its share buyback programme announced on 17 November 2022 ("Share Buyback Programme"), the Company purchased the following number of its Ordinary Shares of £0.01 each ("Ordinary Shares") through Numis Securities Limited. The Ordinary Shares purchased will be held in treasury until transferred by the Company to the directors and employees in satisfaction of awards under the 2014 Long Term Incentive Plan ("LTIP").

 

Date of purchase:

 23 November 2022

Volume of Allied Minds shares purchased:

560,048

Average market price paid per share (GBp):

9.4000

Highest price paid per share (GBp):

9.400

Lowest price paid per share (GBp):

9.400

 

In accordance with Rule 2.9 of The City Code on Takeovers and Mergers, Allied Minds confirms that, as at the date and time of this announcement, the remaining number of Ordinary Shares in issue will be 238,266,961 (excluding treasury shares), and the Company hold 1,383,312 Ordinary Shares in treasury. Therefore, the total voting rights in the Company will be 238,266,961. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. The International Securities Identification Number for Allied Minds Ordinary Shares is GB00BLRLH124.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Numis Securities Limited as part of the Share Buyback Programme.

 

Schedule of Purchases - Individual Transactions

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Transaction reference number

Trading venue

25000

9.40

08:33:49

00062304234TRLO0

LSE

25000

9.40

08:33:49

00062304235TRLO0

LSE

27295

9.40

08:55:59

00062305229TRLO0

LSE

222705

9.40

08:55:59

00062305230TRLO0

LSE

2444

9.40

10:34:55

00062309612TRLO0

LSE

22556

9.40

11:50:10

00062312753TRLO0

LSE

400

9.40

12:28:41

00062314338TRLO0

LSE

17958

9.40

13:08:41

00062316194TRLO0

LSE

8851

9.40

13:30:22

00062316950TRLO0

LSE

26188

9.40

13:30:24

00062316952TRLO0

LSE

25000

9.40

15:41:13

00062326641TRLO0

LSE

75000

9.40

15:41:13

00062326642TRLO0

LSE

9028

9.40

15:41:20

00062326650TRLO0

LSE

12939

9.40

15:45:55

00062327110TRLO0

LSE

3442

9.40

15:50:37

00062327331TRLO0

LSE

56242

9.40

15:50:37

00062327332TRLO0

LSE

 

The Company will make further regulatory announcements to shareholders in respect of purchases of Ordinary Shares by the Company as they occur.

 

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Allied Minds plc

c/o Instinctif Partners

JTC (UK) Limited - Company Secretary

Christopher Gibbons

0203 846 9774

christopher.gibbons@jtcgroup.com 

Instinctif Partners - Communications

Tim Linacre / Rozi Morris / Joe Quinlan

 

alliedminds@instinctif.com

 

The Company's LEI is 213800YB4G7YN21NLL72

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTTUOUBRUBUAUAA
Date   Source Headline
31st Jan 20173:55 pmRNSTotal Voting Rights
30th Jan 201712:02 pmRNSPrice Monitoring Extension
3rd Jan 20172:48 pmRNSHolding(s) in Company
3rd Jan 20172:11 pmRNSTotal Voting Rights
13th Dec 20167:00 amRNSFormation of Signature Medical, Inc.
9th Dec 20165:04 pmRNSHolding(s) in Company
7th Dec 20164:34 pmRNSHolding(s) in Company
6th Dec 20165:05 pmRNSHolding(s) in Company
6th Dec 20165:04 pmRNSHolding(s) in Company
2nd Dec 20167:00 amRNSResults of equity placing
1st Dec 20164:50 pmRNSProposed Equity Placing
23rd Nov 20167:00 amRNSHawkEye 360 Raises $11m in Series A Financing
21st Nov 20167:00 amRNSFormation of Vatic Materials, Inc.
18th Nov 20163:15 pmRNSBlock Listing Six Monthly Return
11th Nov 20165:17 pmRNSHolding(s) in Company
24th Oct 20167:00 amRNSPrecision Biopsy Raises $5.0 Million
17th Oct 201612:07 pmRNSSecond Price Monitoring Extn
17th Oct 201612:02 pmRNSPrice Monitoring Extension
29th Sep 20167:00 amRNSAllied Minds & GE Ventures Form Strategic Alliance
8th Sep 201612:02 pmRNSPrice Monitoring Extension
31st Aug 20165:11 pmRNSTotal Voting Rights
25th Aug 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSAllied Minds Secures $20m Debt Facility from SVB
22nd Aug 20167:00 amRNSAllied Minds' Subsidiary ABLS II Raises $15m
1st Aug 20167:00 amRNSSciFluor Enters Clinical Trial Stage
29th Jul 201610:30 amRNSTotal Voting Rights
13th Jul 201610:02 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:00 amRNSDirector/PDMR Shareholding
7th Jul 20167:00 amRNSLong Term Incentive Plan - Listing Application
30th Jun 20167:00 amRNSTotal Voting Rights
22nd Jun 20164:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20164:35 pmRNSPrice Monitoring Extension
14th Jun 20162:38 pmRNSDirector/PDMR Shareholding
13th Jun 20165:18 pmRNSDirector/PDMR Shareholding
31st May 20164:44 pmRNSBlocklisting Six Monthly Return
26th May 20165:23 pmRNSResult of AGM
26th May 20167:00 amRNSAGM Statement
25th May 20167:00 amRNSABLS II Completes Drug Feasibility Programme
13th May 20167:00 amRNSDirector/PDMR Shareholding
10th May 20164:30 pmRNSLong Term Incentive Plan
28th Apr 201612:33 pmRNSHolding(s) in Company
26th Apr 20167:00 amRNSAllied Minds Raises $80m for ABLS Capital
25th Apr 20167:00 amRNSAnnual Financial Report
19th Apr 20167:00 amRNSAppointment of Joint Broker
16th Mar 20167:00 amRNSABLS agrees license with NYU
10th Feb 20164:40 pmRNSSecond Price Monitoring Extn
10th Feb 20164:36 pmRNSPrice Monitoring Extension
9th Feb 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.